These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31991477)

  • 1. The microbiota and immune-mediated diseases: Opportunities for therapeutic intervention.
    Fitzgibbon G; Mills KHG
    Eur J Immunol; 2020 Mar; 50(3):326-337. PubMed ID: 31991477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
    Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
    World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases.
    Konturek PC; Haziri D; Brzozowski T; Hess T; Heyman S; Kwiecien S; Konturek SJ; Koziel J
    J Physiol Pharmacol; 2015 Aug; 66(4):483-91. PubMed ID: 26348073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential impact of gut microbiota on your health:Current status and future challenges.
    Sirisinha S
    Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.
    Hudson LE; Anderson SE; Corbett AH; Lamb TJ
    Clin Microbiol Rev; 2017 Jan; 30(1):191-231. PubMed ID: 27856521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies.
    West CE; Renz H; Jenmalm MC; Kozyrskyj AL; Allen KJ; Vuillermin P; Prescott SL;
    J Allergy Clin Immunol; 2015 Jan; 135(1):3-13; quiz 14. PubMed ID: 25567038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of commensal microbiota in the treatment and prevention of inflammatory bowel disease.
    Dasgupta S; Kasper DL
    Inflamm Bowel Dis; 2013 Oct; 19(11):2478-89. PubMed ID: 23846489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications.
    Shamoon M; Martin NM; O'Brien CL
    Pharmacol Res; 2019 Oct; 148():104344. PubMed ID: 31400403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.
    Tlaskalová-Hogenová H; Stepánková R; Hudcovic T; Tucková L; Cukrowska B; Lodinová-Zádníková R; Kozáková H; Rossmann P; Bártová J; Sokol D; Funda DP; Borovská D; Reháková Z; Sinkora J; Hofman J; Drastich P; Kokesová A
    Immunol Lett; 2004 May; 93(2-3):97-108. PubMed ID: 15158604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease.
    Wang ZK; Yang YS; Chen Y; Yuan J; Sun G; Peng LH
    World J Gastroenterol; 2014 Oct; 20(40):14805-20. PubMed ID: 25356041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microbiome in autoimmune diseases.
    De Luca F; Shoenfeld Y
    Clin Exp Immunol; 2019 Jan; 195(1):74-85. PubMed ID: 29920643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiota abnormalities in inflammatory airway diseases - Potential for therapy.
    Gollwitzer ES; Marsland BJ
    Pharmacol Ther; 2014 Jan; 141(1):32-9. PubMed ID: 23969226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease.
    Khanna S; Vazquez-Baeza Y; González A; Weiss S; Schmidt B; Muñiz-Pedrogo DA; Rainey JF; Kammer P; Nelson H; Sadowsky M; Khoruts A; Farrugia SL; Knight R; Pardi DS; Kashyap PC
    Microbiome; 2017 May; 5(1):55. PubMed ID: 28506317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota and allergy/asthma: From pathogenesis to new therapeutic strategies.
    Kang YB; Cai Y; Zhang H
    Allergol Immunopathol (Madr); 2017; 45(3):305-309. PubMed ID: 28029408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbes as future therapeutics in treating inflammatory and infectious diseases: Lessons from recent findings.
    Mukherjee S; Joardar N; Sengupta S; Sinha Babu SP
    J Nutr Biochem; 2018 Nov; 61():111-128. PubMed ID: 30196243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gut microbiota, environmental factors, and links to the development of food allergy.
    Lee KH; Song Y; Wu W; Yu K; Zhang G
    Clin Mol Allergy; 2020; 18():5. PubMed ID: 32265597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary Applications of Fecal Microbiota Transplantation to Treat Intestinal Diseases in Humans.
    Staley C; Khoruts A; Sadowsky MJ
    Arch Med Res; 2017 Nov; 48(8):766-773. PubMed ID: 29183720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.